PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
6.67%
Revenue growth below 50% of CSIQ's 17.33%. Michael Burry would check for competitive disadvantage risks.
10.97%
Similar cost growth to CSIQ's 10.95%. Walter Schloss would investigate if industry cost pressures are temporary.
-177.61%
Gross profit decline while CSIQ shows 35.39% growth. Joel Greenblatt would examine competitive position.
-172.76%
Margin decline while CSIQ shows 15.39% expansion. Joel Greenblatt would examine competitive position.
-0.80%
R&D reduction while CSIQ shows 52.00% growth. Joel Greenblatt would examine competitive risk.
-29.30%
G&A reduction while CSIQ shows 38.13% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-24.53%
Operating expenses reduction while CSIQ shows 28.96% growth. Joel Greenblatt would examine advantage.
19.12%
Total costs growth 1.25-1.5x CSIQ's 13.75%. Martin Whitman would scrutinize control.
16.34%
Interest expense growth while CSIQ reduces costs. John Neff would investigate differences.
-2.76%
Both companies reducing D&A. Martin Whitman would check industry patterns.
7.87%
EBITDA growth below 50% of CSIQ's 37.77%. Michael Burry would check for structural issues.
13.64%
Similar EBITDA margin growth to CSIQ's 17.42%. Walter Schloss would investigate industry trends.
33.93%
Similar operating income growth to CSIQ's 42.40%. Walter Schloss would investigate industry trends.
38.06%
Operating margin growth exceeding 1.5x CSIQ's 21.37%. David Dodd would verify competitive advantages.
-371.19%
Other expenses reduction while CSIQ shows 188.80% growth. Joel Greenblatt would examine advantage.
-65.33%
Pre-tax income decline while CSIQ shows 90.49% growth. Joel Greenblatt would examine position.
-54.99%
Pre-tax margin decline while CSIQ shows 62.35% growth. Joel Greenblatt would examine position.
-327.69%
Tax expense reduction while CSIQ shows 173.29% growth. Joel Greenblatt would examine advantage.
-76.09%
Net income decline while CSIQ shows 67.69% growth. Joel Greenblatt would examine position.
-65.08%
Net margin decline while CSIQ shows 42.93% growth. Joel Greenblatt would examine position.
-75.00%
EPS decline while CSIQ shows 65.79% growth. Joel Greenblatt would examine position.
-75.00%
Diluted EPS decline while CSIQ shows 66.06% growth. Joel Greenblatt would examine position.
0.08%
Share count reduction exceeding 1.5x CSIQ's 1.08%. David Dodd would verify capital allocation.
0.08%
Diluted share reduction exceeding 1.5x CSIQ's 0.68%. David Dodd would verify capital allocation.